Enliven Therapeutics, Inc.

Historical 13F Holders

Symbol
ELVN
CUSIP
29337E102
All holders as of
Q1 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q1 184 62.6 M $2.44 B
2025 Q4 131 62.0 M $955 M
2025 Q3 138 59.4 M $1.22 B
2025 Q2 129 59.5 M $1.19 B
2025 Q1 127 49.9 M $984 M
2024 Q4 118 49.6 M $1.12 B
2024 Q3 107 47.7 M $1.22 B
2024 Q2 103 49.0 M $1.15 B
2024 Q1 78 44.6 M $783 M
2023 Q4 66 39.1 M $542 M
2023 Q3 64 39.1 M $534 M
2023 Q2 65 39.1 M $798 M
2023 Q1 48 33.6 M $735 M